KELLY BRITNELL: Open Payments
NPI 1467999755 · FLORENCE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$700 in 35 payments from 11 companies in 2025. Trend: 2023 $654 · 2024 $501 · 2025 $700
Food & beverage: $700
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $172 |
| ABBVIE INC. | 11 | $141 |
| Phathom Pharmaceuticals, Inc. | 1 | $127 |
| Novo Nordisk Inc | 3 | $67 |
| Antares Pharma, Inc. | 2 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| Exact Sciences Corporation | 1 | $15 |
Products named: VOQUEZNA, ZEPBOUND, UBRELVY, MOUNJARO, XYOSTED, QULIPTA, Wegovy, FARXIGA.
Industry payments across AL — which companies pay providers there.
